Insulin lispro low mixture

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

Type 2 Diabetes Mellitus

Phase 4

Efficacy and Safety of Twice-Daily Insulin Lispro Low Mixture Compared to a Once-Daily Long Acting Insulin Comparator in Patients Who Have Been Using One or More Oral Antihyperglycemic Agents Without Insulin

CompletedNCT00036504

Eli Lilly and CompanyType 2 Diabetes Mellitus

Start: 2001-08-31End: 2002-08-31Target: 100Updated: 2010-10-13

A Study for Type 2 Diabetic Patients

CompletedNCT00548808

Eli Lilly and CompanyType 2 Diabetes Mellitus

Start: 2007-11-30End: 2009-08-31Updated: 2010-09-15